ROR1 associates unfavorable prognosis and promotes lymphoma growth in DLBCL by affecting PI3K/Akt/mTOR signaling pathway-Reference-Cited by-同舟云学术

ROR1 associates unfavorable prognosis and promotes lymphoma growth in DLBCL by affecting PI3K/Akt/mTOR signaling pathway

Published:2019-02-24 Issue:3 Volume:45 Page:416-426
ISSN:0951-6433
Container-title:BioFactors
language:en
Short-container-title:BioFactors

Author:

Mao Yuan¹,Xu Li²,Wang Jun¹,Zhang Louqian³,Hou Nan¹⁴,Xu Juqing¹,Wang Lin¹,Yang Shu¹,Chen Yan²,Xiong Lin⁵,Zhu Jin⁶,Fan Weifei¹^ORCID,Xu Jiaren¹⁴

Affiliation:

1. Department of Hematology and Oncology, Department of Geriatric Lung Cancer LaboratoryGeriatric Hospital of Nanjing Medical University, Jiangsu Province Geriatric Hospital Nanjing China

2. Department of PathologyJiangsu Cancer Hospital, Affiliated Cancer Hospital of Nanjing Medical University Nanjing Jiangsu China

3. Department of Thoracic SurgeryNanjing Medical University Affiliated Cancer Hospital, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Cancer Institute of Jiangsu Province Nanjing Jiangsu China

4. Department of Hematology and OncologyThe Second Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu China

5. Department of PathologyThe Second Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu China

6. Huadong Medical Institute of Biotechniques Nanjing China

Funder

Natural Science Foundation of Jiangsu Province

Publisher

Wiley

Subject

Clinical Biochemistry,Molecular Medicine,General Medicine,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/biof.1498

Reference40 articles.

1. Prognostic Significance of EBV Latent Membrane Protein 1 Expression in Lymphomas: Evidence from 15 Studies

2. Cancer statistics in China, 2015

3. Non-Hodgkin lymphoma

4. Clinical significance of chemokine receptor CXCR4 and mammalian target of rapamycin (mTOR) expression in patients with diffuse large B-cell lymphoma

5. Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fat mass and obesity-associated protein (FTO)-induced upregulation of flotillin-2 (FLOT2) contributes to cancer aggressiveness in diffuse large B-cell lymphoma (DLBCL) via activating the PI3K/Akt/mTOR signal pathway;Archives of Biochemistry and Biophysics;2024-08

2. Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway;International Journal of Molecular Sciences;2024-06-26

3. Heterogeneous Profile of ROR1 Protein Expression across Tumor Types;Cancers;2024-05-15

4. The expression characteristic and prognostic role of Siglec‐15 in lung adenocarcinoma;The Clinical Respiratory Journal;2024-05

5. Targeting Other Promising Cell Surface Receptors;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21